MBRS-42. GMYC: A NOVEL INDUCIBLE TRANSGENIC MODEL OF GROUP 3 MEDULLOBLASTOMA

Group 3 medulloblastoma (MB) carry the worst prognosis of all MB. The transcription factors MYC and MYCN have been suggested as drivers for a subset of these tumors, with MYC amplifications (17-20%) representing the most common genetic alteration in Group 3 tumors, while MYCN amplifications (4-6%) a...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Neuro Oncol
Autori principali: Weishaupt, Holger, Mainwaring, Oliver, Hutter, Sonja, Kalushkova, Antonia, Jernberg-Wiklund, Helena, Rosén, Gabriela, Swartling, Fredrik J
Natura: Artigo
Lingua:Inglês
Pubblicazione: Oxford University Press 2018
Soggetti:
Abstracts
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6012900/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noy059.487
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi